Shao-Lee Lin insider trades
Open-market stock purchases and sales by Shao-Lee Lin, Chief Executive Officer at Cue Biopharma, Inc, from SEC Form 4 filings since Jan 4, 2018.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +72%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 12, 2026 | CUE Cue Biopharma, Inc | Sold | $275K |
| Oct 12, 2026 | CUE Cue Biopharma, Inc | Sold | $30.5K |
| Aug 13, 2026 | CUE Cue Biopharma, Inc | Sold | $147K |
| Aug 13, 2026 | CUE Cue Biopharma, Inc | Sold | $66.8K |
| Aug 13, 2026 | CUE Cue Biopharma, Inc | Sold | $308K |
| Aug 12, 2026 | CUE Cue Biopharma, Inc | Sold | $924K |
| Aug 12, 2026 | CUE Cue Biopharma, Inc | Sold | $160K |
| Aug 12, 2026 | CUE Cue Biopharma, Inc | Bought (not open market) | — |
| Jul 9, 2026 | CUE Cue Biopharma, Inc | Bought (not open market) | — |
| Jun 1, 2026 | CUE Cue Biopharma, Inc | Bought | $1M |
| Jun 1, 2026 | CUE Cue Biopharma, Inc | Bought | $500K |
| Jun 1, 2026 | CUE Cue Biopharma, Inc | Bought (not open market) | $1M |
| Jun 1, 2026 | CUE Cue Biopharma, Inc | Bought (not open market) | $500K |
| May 3, 2026 | CUE Cue Biopharma, Inc | Bought (not open market) | — |
| May 3, 2026 | CUE Cue Biopharma, Inc | Bought (not open market) | — |
Companies traded
- CUE Cue Biopharma, Inc: 2 buys, 7 sales, last Oct 12, 2026
- SRZN Surrozen, Inc./DE: other filings, last May 14, 2025
- SLRN ACELYRIN, Inc: 3 sales, last Apr 1, 2024
- THRD Third Harmonic Bio, Inc: other filings, last Oct 26, 2022
- PRNB Principia Biopharma Inc: other filings, last Sep 28, 2020
- HZNP Horizon Therapeutics Public Ltd Co: other filings, last Jan 21, 2020